Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Virax Biolabs (VRAX) has a market cap of $4.314 million USD. According to our data, Virax Biolabs is ranked No.9039 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $4.31 M |
-55.84%
|
| Dec 31, 2024 | $9.77 M |
54.11%
|
| Dec 29, 2023 | $6.34 M |
-80.00%
|
| Dec 30, 2022 | $31.70 M |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Thermo Fisher Scientific
TMO
|
$161.38 B |
-0.001 M
|
USA
|
 Bio-Rad Laboratories
BIO
|
$6.69 B |
1.227 B
|
USA
|
 Agilent Technologies
A
|
$29.22 B |
0.001 M
|
USA
|
 Illumina
ILMN
|
$11.27 B |
-0.000 M
|
USA
|
 Qiagen
QGEN
|
$8.80 B |
-0.000 M
|
Netherlands
|
 Danaher
DHR
|
$133.67 B |
-0.001 M
|
USA
|
 Becton Dickinson
BDX
|
$57.06 B |
0.001 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Abbott Laboratories
ABT
|
$227.16 B |
0.001 M
|
USA
|
 Hologic
HOLX
|
$12.99 B |
-0.000 M
|
USA
|
 Charles River Laboratories
CRL
|
$5.21 B |
0.000 M
|
USA
|
 Bio-Techne
TECH
|
$7.60 B |
-0.000 M
|
USA
|
| Market Cap | = | VRAX Stock Price | * | VRAX Shares Outstanding |
| = | $0.99 | * | 4.34 M | |
| = | $4.31 M |